400 patients monitored for hidden heart and steroid risks in common inflammatory diseases
NCT ID NCT07084480
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 400 adults diagnosed with giant cell arteritis or polymyalgia rheumatica to track serious side effects over time. Researchers will monitor for new or worsening aortic aneurysms and aortic dissections, as well as steroid-related complications. The goal is to better understand long-term risks and improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universitätsklinikum Würzburg
RECRUITINGWürzburg, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues in the blood may foretell heart trouble
- New tool could predict who will suffer from steroid side effects
- Shorter steroid course may be just as effective for giant cell arteritis
- New Total-Body PET scanner could revolutionize vasculitis diagnosis
- New study links common arthritis treatments to diabetes risk
- New scan could spot hidden artery disease faster